Blood Transfusion by Boston MedFlight Registry

Mass General Brigham

Status: Enrolling

Conditions: Hemorrhagic Shock

Study type: Observational

Funder types: Other

Identifiers

NCT04610814

2019P003733

Details and patient eligibility

About

The primary aim of this observational registry is to study the outcomes of patients with hemorrhagic shock transported by Boston MedFlight receiving blood products during transport.

Full description

Boston MedFlight, a critical care transport organization, based on a consortium of the academic medical centers in Boston, will begin carrying PRBC in 2019. The program is intended to provide BMF clinicians with 24-hour immediate access to appropriate blood products to be utilized if needed for patients following life-threatening illness or injury. The four fundamental goals of this program are: save lives' ensure transfusion safety; minimize blood product waste; and conduct continuous quality assurance. Our goal is to observationally evaluate this new protocol of administering blood products in the pre-hospital setting. We will collect data on patients with hemorrhagic shock being transported by Boston MedFlight, who receive or would have been eligible to receive pre-hospital blood transfusion by the inclusion criteria.

Enrollment: 500 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Adult patients who would be eligible to receive blood products;

  • systolic blood pressure <90 mmHg
  • a shock index of > 0.9
  • clinical signs of shock as determined by the transport clinicians.

Exclusion criteria

• Age < 18 years old

Trial design

500 participants in 2 patient groups

Blood products during transport

Description:

Administration of appropriate blood products during transport

Standard of Care

Description:

Receiving standard prehospital air medical care